Is there a need to widely prescribe antibiotics in patients hospitalized for COVID-19?

  26 January 2021

All patients hospitalized in the infectious diseases department of Dijon (France) between the 27th of February and the 30th of April 2020 for a confirmed COVID-19 were included. Clinical, biological and radiological data were collected, as well as treatments and outcomes. An unfavorable outcome was defined as death or transfer to intensive care unit. We compared the characteristics and outcomes between patients with and without antibiotics using propensity score matching.

Among the 222 patients included, 174 (78%) were on antibiotics. The univariate analysis showed that patients with antibiotics were significantly older, frailer and with a more severe presentation at admission.

Antibiotics were frequently prescribed in our study and associated with a more severe presentation at admission. However, receiving antibiotics was not associated with outcome, either after adjustment on a propensity score. In line with recent publication, such data argue for streamlining of antibiotic therapies in COVID-19 patients.

Author(s): Moretto F. Sixt T. Devilliers H. Abdallahoui M. Eberl I. Rogier T. Buisson M. Chavanet P. Duong M. Esteve C. Mahy S. Salmon-Rousseau A. Catherine F. Blot M.
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!